Phibro Animal Health (PAHC) Profit After Tax (QoQ) (2012 - 2026)
Phibro Animal Health (PAHC) Profit After Tax (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.32% |
| Dec 31, 2025 | -17.74% |
| Sep 30, 2025 | 77.22% |
| Jun 30, 2025 | -17.51% |
| Mar 31, 2025 | 396.38% |
| Dec 31, 2024 | -207.28% |
| Sep 30, 2024 | 773.27% |
| Jun 30, 2024 | -91.05% |
| Mar 31, 2024 | 234.19% |
| Dec 31, 2023 | 153.96% |
| Sep 30, 2023 | -140.54% |
| Jun 30, 2023 | 14.50% |
| Mar 31, 2023 | -4.12% |
| Dec 31, 2022 | 102.44% |
| Sep 30, 2022 | -30.89% |
| Jun 30, 2022 | -57.67% |
| Mar 31, 2022 | 63.03% |
| Dec 31, 2021 | 3,080.77% |
| Sep 30, 2021 | -102.44% |
| Jun 30, 2021 | 22.84% |